Global Blood Purification Cartridge Market Growth 2026-2032
The global Blood Purification Cartridge market size is predicted to grow from US$ 7058 million in 2025 to US$ 11145 million in 2032; it is expected to grow at a CAGR of 6.8% from 2026 to 2032.
Blood Purification Cartridge is a disposable extracorporeal blood purification consumable designed to remove selected endogenous or exogenous substances from whole blood or separated plasma through adsorption. The product typically takes the form of a cartridge or adsorption column containing synthetic resin, activated carbon, cellulose-based beads, immobilized fibers, or affinity sorbents. Depending on sorbent chemistry, pore structure, ligand design, and surface properties, Blood Purification Cartridge can provide broad-spectrum adsorption or selective removal of target substances such as uremic toxins, inflammatory mediators, endotoxin, drugs and poisons, bilirubin and other liver-related toxins, ?2-microglobulin, immune-related substances, and lipoproteins. The research scope covers both whole-blood hemoperfusion cartridges and plasma adsorption columns, with downstream use concentrated in hemodialysis and renal care, critical care, poisoning treatment, liver support, immune-mediated diseases, dialysis-related complications, cardiovascular surgery, and selected metabolic disorders. These cartridges operate as functional consumables within extracorporeal circulation systems and are differentiated primarily by adsorption material, molecular selectivity, adsorption capacity, hemocompatibility, treatment mode, and compatibility with dialysis or other extracorporeal platforms.
Key Findings
In 2025, global Blood Purification Cartridge production reached approximately 534 million units
Selective adsorption expands Blood Purification Cartridge use across targeted molecules
Synthetic resin is a core material for broad-spectrum adsorption cartridges
Dialysis and critical care remain major downstream application settings
Differentiation centers on selectivity biocompatibility and circuit compatibility
Market Trends
The Blood Purification Cartridge market is moving from relatively generalized adsorption toward a more diversified structure combining broad-spectrum removal with molecule- or disease-oriented selective adsorption. Resin-based hemoperfusion remains important for removal of middle- and larger-molecular-weight toxins and inflammatory mediators, while specialized technologies use immobilized fibers, functionalized cellulose beads, ligands, and engineered polymer structures to target endotoxin, ?2-microglobulin, immune complexes, autoantibodies, bilirubin, or other defined substances. This transition is shifting product evaluation from simple adsorption capacity toward selectivity, hemocompatibility, preservation of beneficial blood components, pressure characteristics, and predictable integration with dialysis, CRRT, cardiopulmonary bypass, and other extracorporeal circuits. Products are also increasingly positioned around defined clinical pathways rather than as stand-alone generic detoxification cartridges. Jafron’s resin hemoperfusion products, Toray’s endotoxin-selective fiber technology, Kaneka’s ?2-microglobulin adsorption system, Asahi Kasei Medical’s plasma adsorption technologies, and CytoSorbents’ porous polymer platform illustrate the technological diversity already present within the confirmed competitive universe.
Market Dynamics
Drivers
Demand for Blood Purification Cartridge is supported by the continuing clinical burden of chronic kidney disease, dialysis-related complications, severe inflammatory conditions, acute poisoning, liver dysfunction, and other disorders involving circulating pathogenic substances. Unlike conventional dialysis, which primarily relies on diffusion and convection, adsorption can address substances that are poorly removed by traditional membrane-based purification because of molecular size, protein binding, or physicochemical characteristics. The ability to combine adsorption cartridges with existing extracorporeal platforms also lowers the infrastructure barrier for hospitals already operating dialysis, CRRT, or cardiopulmonary bypass systems. At the product level, advances in porous polymer beads, resin chemistry, ligand immobilization, surface modification, and hemocompatible materials are expanding the range of molecules that can be addressed and supporting more differentiated clinical use.
Restraints
Market expansion remains constrained by the requirement for indication-specific clinical evidence, treatment protocols, regulatory authorization, and hospital expertise in extracorporeal therapy. Adsorption performance alone does not determine commercial adoption; clinicians also evaluate whether treatment can selectively reduce clinically relevant substances without excessive removal of beneficial proteins, drugs, or other blood components. Cartridge cost must additionally be considered together with extracorporeal circuit time, anticoagulation, staffing, and supporting equipment. Regulatory status can differ significantly by country and indication, limiting the ability of a single product platform to achieve identical commercial positioning across regions. CytoSorbents, for example, reports EU authorization for CytoSorb while its current regulatory status remains different in the United States and Canada, illustrating the importance of region-specific approval pathways in this market.
Opportunities
The principal opportunity is the transition from generalized blood detoxification toward more precisely defined adsorption therapies. Selective cartridges targeting endotoxin, ?2-microglobulin, immune-related substances, bilirubin, lipoproteins, specific drugs, and inflammatory mediators allow manufacturers to build differentiated products around identifiable clinical needs rather than compete solely on cartridge volume or price. Additional opportunity exists in combination therapy, where Blood Purification Cartridge can be connected with hemodialysis, CRRT, plasma separation, cardiopulmonary bypass, or other extracorporeal circuits. This supports expansion into renal care, critical care, liver support, cardiovascular procedures, and immune-related treatment settings. Technologies that improve target selectivity, adsorption efficiency, hemocompatibility, ease of operation, and compatibility with commonly installed extracorporeal equipment are positioned to capture greater clinical value.
Challenges
The long-term challenge for the Blood Purification Cartridge industry is converting technically measurable adsorption performance into reproducible clinical and economic value. Treatment timing, cartridge duration, patient selection, target concentration, anticoagulation strategy, and combination with other extracorporeal therapies can influence treatment outcomes and make protocol standardization difficult. The market also spans highly different indications, from chronic dialysis-related toxin removal to emergency poisoning and critical-care inflammatory control, meaning one technical platform cannot automatically address every clinical segment. Manufacturers therefore face simultaneous requirements for clinical validation, regulatory compliance, physician education, manufacturing consistency, and cost control. Competitive pressure is also increasingly technology-specific, as broad-spectrum resin products compete not only with other adsorption cartridges but, in some indications, with dialysis membranes, plasma exchange, double-filtration plasmapheresis, and other extracorporeal purification approaches.
Industry Chain Analysis
The upstream value base of Blood Purification Cartridge is concentrated in adsorption media and medical-grade cartridge materials. Core inputs include synthetic adsorption resins, activated carbon, porous polymer beads, cellulose-based carriers, functional ligands, immobilized fibers, medical-grade polymers for housings and connectors, membranes or screens used to retain sorbent media, and sterilization and packaging materials. The technical barrier is substantially higher than simple cartridge assembly because adsorption media must achieve controlled pore distribution, adequate surface area, defined chemical affinity, low extractables, mechanical stability, sterilization resistance, and suitable blood compatibility. Functionalization and surface treatment determine which molecules are preferentially captured and therefore represent an important source of product differentiation.
The midstream covers adsorbent preparation, cartridge engineering, filling and sealing, sterilization, quality control, clinical validation, regulatory registration, and integration testing with extracorporeal blood circuits. Downstream value is created through hospitals, dialysis centers, intensive care units, emergency and poisoning treatment, liver-support programs, cardiovascular surgery, and specialist therapeutic apheresis. For broad-spectrum cartridges, manufacturing scale, quality consistency, hospital access, and cost efficiency are commercially important; for highly selective adsorption columns, intellectual property around sorbent chemistry, ligand design, clinical evidence, and indication-specific positioning can account for a larger part of value creation. As a result, industry profitability is determined less by the physical cartridge housing than by the proprietary adsorption medium, clinical evidence, regulatory access, and established treatment pathway surrounding the consumable.
Segment Insights
By adsorbent material, the market includes synthetic resin, activated carbon, cellulose-based adsorbents, immobilized-fiber systems, and affinity sorbents. Synthetic resin products are particularly relevant to broad-spectrum hemoperfusion because porous structures and large adsorption surface areas allow removal of multiple middle- and larger-molecular-weight substances. More specialized segments rely on engineered cellulose carriers, immobilized functional molecules, or affinity ligands to increase selectivity. The strategic distinction is therefore evolving from material category alone toward the relationship between material architecture and target molecule: pore size, hydrophobicity, ionic interaction, ligand affinity, and surface compatibility collectively determine the commercial positioning of each cartridge.
By treatment mode, whole-blood hemoperfusion and plasma adsorption form two structurally different segments. Whole-blood cartridges provide direct contact between circulating blood and the sorbent and are suited to applications where efficient extracorporeal integration and broad or targeted adsorption are required. Plasma adsorption first separates plasma and then passes it through an adsorption column, allowing more selective removal of certain pathogenic plasma components. Within these modes, the confirmed product structure extends from broad-spectrum adsorption to selective and highly selective affinity systems, and from uremic toxins and inflammatory mediators to endotoxin, drugs, bilirubin, ?2-microglobulin, immune-related substances, and lipoproteins.
Downstream Market Opportunities
Renal care remains an important commercial foundation because Blood Purification Cartridge can complement conventional hemodialysis in the removal of substances that are insufficiently addressed by diffusion-based treatment, while selective products serve dialysis-related complications such as ?2-microglobulin accumulation. Critical care represents another major opportunity as adsorption technologies are applied to excessive inflammatory mediators, endotoxin, and other circulating substances in complex extracorporeal treatment pathways. Beyond these areas, acute poisoning, liver support, immune-mediated diseases, cardiovascular surgery, and severe lipid disorders create more specialized demand. The commercial opportunity is strongest where a cartridge addresses a clearly defined unmet removal target, can be incorporated into an existing extracorporeal workflow, and is supported by a clinically recognizable patient population.
Regional Insights
Regional development of the Blood Purification Cartridge market reflects different treatment practices, regulatory pathways, and supplier structures. Asia-Pacific has a particularly diversified product landscape within the confirmed research universe, ranging from Chinese broad-spectrum synthetic-resin hemoperfusion cartridges to Japanese selective adsorption systems targeting endotoxin, ?2-microglobulin, and pathogenic plasma components. The region therefore combines large-scale renal-care applications with highly specialized adsorption technologies. Europe has developed an established commercialization environment for cytokine and other hemoadsorption technologies and also has demand in critical care, cardiovascular surgery, renal support, and liver-related applications.
North American market development is comparatively more sensitive to product-specific regulatory status and approved indications. This creates a regional structure in which the same adsorption technology may have different commercial availability, positioning, or clinical penetration across markets. Emerging markets offer longer-term potential through expansion of dialysis infrastructure, intensive-care capacity, and extracorporeal treatment capabilities, but commercialization is likely to depend on affordability, physician training, reimbursement, and availability of compatible blood-purification equipment. Consequently, regional opportunity should be assessed by individual indication and regulatory pathway rather than by hospital demand alone.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Blood Purification Cartridge Industry Forecast” looks at past sales and reviews total world Blood Purification Cartridge sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood Purification Cartridge sales for 2026 through 2032. With Blood Purification Cartridge sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Purification Cartridge industry.
This Insight Report provides a comprehensive analysis of the global Blood Purification Cartridge landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Purification Cartridge portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Purification Cartridge market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Purification Cartridge and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Purification Cartridge.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Purification Cartridge market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Blood Purification Cartridge is a disposable extracorporeal blood purification consumable designed to remove selected endogenous or exogenous substances from whole blood or separated plasma through adsorption. The product typically takes the form of a cartridge or adsorption column containing synthetic resin, activated carbon, cellulose-based beads, immobilized fibers, or affinity sorbents. Depending on sorbent chemistry, pore structure, ligand design, and surface properties, Blood Purification Cartridge can provide broad-spectrum adsorption or selective removal of target substances such as uremic toxins, inflammatory mediators, endotoxin, drugs and poisons, bilirubin and other liver-related toxins, ?2-microglobulin, immune-related substances, and lipoproteins. The research scope covers both whole-blood hemoperfusion cartridges and plasma adsorption columns, with downstream use concentrated in hemodialysis and renal care, critical care, poisoning treatment, liver support, immune-mediated diseases, dialysis-related complications, cardiovascular surgery, and selected metabolic disorders. These cartridges operate as functional consumables within extracorporeal circulation systems and are differentiated primarily by adsorption material, molecular selectivity, adsorption capacity, hemocompatibility, treatment mode, and compatibility with dialysis or other extracorporeal platforms.
Key Findings
In 2025, global Blood Purification Cartridge production reached approximately 534 million units
Selective adsorption expands Blood Purification Cartridge use across targeted molecules
Synthetic resin is a core material for broad-spectrum adsorption cartridges
Dialysis and critical care remain major downstream application settings
Differentiation centers on selectivity biocompatibility and circuit compatibility
Market Trends
The Blood Purification Cartridge market is moving from relatively generalized adsorption toward a more diversified structure combining broad-spectrum removal with molecule- or disease-oriented selective adsorption. Resin-based hemoperfusion remains important for removal of middle- and larger-molecular-weight toxins and inflammatory mediators, while specialized technologies use immobilized fibers, functionalized cellulose beads, ligands, and engineered polymer structures to target endotoxin, ?2-microglobulin, immune complexes, autoantibodies, bilirubin, or other defined substances. This transition is shifting product evaluation from simple adsorption capacity toward selectivity, hemocompatibility, preservation of beneficial blood components, pressure characteristics, and predictable integration with dialysis, CRRT, cardiopulmonary bypass, and other extracorporeal circuits. Products are also increasingly positioned around defined clinical pathways rather than as stand-alone generic detoxification cartridges. Jafron’s resin hemoperfusion products, Toray’s endotoxin-selective fiber technology, Kaneka’s ?2-microglobulin adsorption system, Asahi Kasei Medical’s plasma adsorption technologies, and CytoSorbents’ porous polymer platform illustrate the technological diversity already present within the confirmed competitive universe.
Market Dynamics
Drivers
Demand for Blood Purification Cartridge is supported by the continuing clinical burden of chronic kidney disease, dialysis-related complications, severe inflammatory conditions, acute poisoning, liver dysfunction, and other disorders involving circulating pathogenic substances. Unlike conventional dialysis, which primarily relies on diffusion and convection, adsorption can address substances that are poorly removed by traditional membrane-based purification because of molecular size, protein binding, or physicochemical characteristics. The ability to combine adsorption cartridges with existing extracorporeal platforms also lowers the infrastructure barrier for hospitals already operating dialysis, CRRT, or cardiopulmonary bypass systems. At the product level, advances in porous polymer beads, resin chemistry, ligand immobilization, surface modification, and hemocompatible materials are expanding the range of molecules that can be addressed and supporting more differentiated clinical use.
Restraints
Market expansion remains constrained by the requirement for indication-specific clinical evidence, treatment protocols, regulatory authorization, and hospital expertise in extracorporeal therapy. Adsorption performance alone does not determine commercial adoption; clinicians also evaluate whether treatment can selectively reduce clinically relevant substances without excessive removal of beneficial proteins, drugs, or other blood components. Cartridge cost must additionally be considered together with extracorporeal circuit time, anticoagulation, staffing, and supporting equipment. Regulatory status can differ significantly by country and indication, limiting the ability of a single product platform to achieve identical commercial positioning across regions. CytoSorbents, for example, reports EU authorization for CytoSorb while its current regulatory status remains different in the United States and Canada, illustrating the importance of region-specific approval pathways in this market.
Opportunities
The principal opportunity is the transition from generalized blood detoxification toward more precisely defined adsorption therapies. Selective cartridges targeting endotoxin, ?2-microglobulin, immune-related substances, bilirubin, lipoproteins, specific drugs, and inflammatory mediators allow manufacturers to build differentiated products around identifiable clinical needs rather than compete solely on cartridge volume or price. Additional opportunity exists in combination therapy, where Blood Purification Cartridge can be connected with hemodialysis, CRRT, plasma separation, cardiopulmonary bypass, or other extracorporeal circuits. This supports expansion into renal care, critical care, liver support, cardiovascular procedures, and immune-related treatment settings. Technologies that improve target selectivity, adsorption efficiency, hemocompatibility, ease of operation, and compatibility with commonly installed extracorporeal equipment are positioned to capture greater clinical value.
Challenges
The long-term challenge for the Blood Purification Cartridge industry is converting technically measurable adsorption performance into reproducible clinical and economic value. Treatment timing, cartridge duration, patient selection, target concentration, anticoagulation strategy, and combination with other extracorporeal therapies can influence treatment outcomes and make protocol standardization difficult. The market also spans highly different indications, from chronic dialysis-related toxin removal to emergency poisoning and critical-care inflammatory control, meaning one technical platform cannot automatically address every clinical segment. Manufacturers therefore face simultaneous requirements for clinical validation, regulatory compliance, physician education, manufacturing consistency, and cost control. Competitive pressure is also increasingly technology-specific, as broad-spectrum resin products compete not only with other adsorption cartridges but, in some indications, with dialysis membranes, plasma exchange, double-filtration plasmapheresis, and other extracorporeal purification approaches.
Industry Chain Analysis
The upstream value base of Blood Purification Cartridge is concentrated in adsorption media and medical-grade cartridge materials. Core inputs include synthetic adsorption resins, activated carbon, porous polymer beads, cellulose-based carriers, functional ligands, immobilized fibers, medical-grade polymers for housings and connectors, membranes or screens used to retain sorbent media, and sterilization and packaging materials. The technical barrier is substantially higher than simple cartridge assembly because adsorption media must achieve controlled pore distribution, adequate surface area, defined chemical affinity, low extractables, mechanical stability, sterilization resistance, and suitable blood compatibility. Functionalization and surface treatment determine which molecules are preferentially captured and therefore represent an important source of product differentiation.
The midstream covers adsorbent preparation, cartridge engineering, filling and sealing, sterilization, quality control, clinical validation, regulatory registration, and integration testing with extracorporeal blood circuits. Downstream value is created through hospitals, dialysis centers, intensive care units, emergency and poisoning treatment, liver-support programs, cardiovascular surgery, and specialist therapeutic apheresis. For broad-spectrum cartridges, manufacturing scale, quality consistency, hospital access, and cost efficiency are commercially important; for highly selective adsorption columns, intellectual property around sorbent chemistry, ligand design, clinical evidence, and indication-specific positioning can account for a larger part of value creation. As a result, industry profitability is determined less by the physical cartridge housing than by the proprietary adsorption medium, clinical evidence, regulatory access, and established treatment pathway surrounding the consumable.
Segment Insights
By adsorbent material, the market includes synthetic resin, activated carbon, cellulose-based adsorbents, immobilized-fiber systems, and affinity sorbents. Synthetic resin products are particularly relevant to broad-spectrum hemoperfusion because porous structures and large adsorption surface areas allow removal of multiple middle- and larger-molecular-weight substances. More specialized segments rely on engineered cellulose carriers, immobilized functional molecules, or affinity ligands to increase selectivity. The strategic distinction is therefore evolving from material category alone toward the relationship between material architecture and target molecule: pore size, hydrophobicity, ionic interaction, ligand affinity, and surface compatibility collectively determine the commercial positioning of each cartridge.
By treatment mode, whole-blood hemoperfusion and plasma adsorption form two structurally different segments. Whole-blood cartridges provide direct contact between circulating blood and the sorbent and are suited to applications where efficient extracorporeal integration and broad or targeted adsorption are required. Plasma adsorption first separates plasma and then passes it through an adsorption column, allowing more selective removal of certain pathogenic plasma components. Within these modes, the confirmed product structure extends from broad-spectrum adsorption to selective and highly selective affinity systems, and from uremic toxins and inflammatory mediators to endotoxin, drugs, bilirubin, ?2-microglobulin, immune-related substances, and lipoproteins.
Downstream Market Opportunities
Renal care remains an important commercial foundation because Blood Purification Cartridge can complement conventional hemodialysis in the removal of substances that are insufficiently addressed by diffusion-based treatment, while selective products serve dialysis-related complications such as ?2-microglobulin accumulation. Critical care represents another major opportunity as adsorption technologies are applied to excessive inflammatory mediators, endotoxin, and other circulating substances in complex extracorporeal treatment pathways. Beyond these areas, acute poisoning, liver support, immune-mediated diseases, cardiovascular surgery, and severe lipid disorders create more specialized demand. The commercial opportunity is strongest where a cartridge addresses a clearly defined unmet removal target, can be incorporated into an existing extracorporeal workflow, and is supported by a clinically recognizable patient population.
Regional Insights
Regional development of the Blood Purification Cartridge market reflects different treatment practices, regulatory pathways, and supplier structures. Asia-Pacific has a particularly diversified product landscape within the confirmed research universe, ranging from Chinese broad-spectrum synthetic-resin hemoperfusion cartridges to Japanese selective adsorption systems targeting endotoxin, ?2-microglobulin, and pathogenic plasma components. The region therefore combines large-scale renal-care applications with highly specialized adsorption technologies. Europe has developed an established commercialization environment for cytokine and other hemoadsorption technologies and also has demand in critical care, cardiovascular surgery, renal support, and liver-related applications.
North American market development is comparatively more sensitive to product-specific regulatory status and approved indications. This creates a regional structure in which the same adsorption technology may have different commercial availability, positioning, or clinical penetration across markets. Emerging markets offer longer-term potential through expansion of dialysis infrastructure, intensive-care capacity, and extracorporeal treatment capabilities, but commercialization is likely to depend on affordability, physician training, reimbursement, and availability of compatible blood-purification equipment. Consequently, regional opportunity should be assessed by individual indication and regulatory pathway rather than by hospital demand alone.
Report Scope
LP Information, Inc. (LPI) ' newest research report, the “Blood Purification Cartridge Industry Forecast” looks at past sales and reviews total world Blood Purification Cartridge sales in 2025, providing a comprehensive analysis by region and market sector of projected Blood Purification Cartridge sales for 2026 through 2032. With Blood Purification Cartridge sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Blood Purification Cartridge industry.
This Insight Report provides a comprehensive analysis of the global Blood Purification Cartridge landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Blood Purification Cartridge portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Blood Purification Cartridge market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Blood Purification Cartridge and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Blood Purification Cartridge.
This report presents a comprehensive overview, market shares, and growth opportunities of Blood Purification Cartridge market by product type, application, key manufacturers and key regions and countries.
Market Segmentation
Segmentation by Type:
- Hemodialyzer
- Hemofilter
- Hemoperfusion Cartridge
- Other
Segmentation by Adsorption Selectivity:
- Broad-spectrum Adsorption Cartridges
- Selective Adsorption Cartridges
Segmentation by Primary Target Substance:
- Uremic Toxin Adsorption Cartridges
- Cytokine and Inflammatory Mediator Adsorption Cartridges
- Endotoxin Adsorption Cartridges
- Drug and Poison Adsorption Cartridges
- Bilirubin and Liver Toxin Adsorption Cartridges
- Other
Segmentation by Application:
- Hospital
- Dialysis Center
- Other
This report also splits the market by region:
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Fresenius
- Nikkiso
- B. Braun
- Baxter
- Asahi Kasei
- Nipro
- Weigao Group
- Toray
- Medtronic
- JMS
- SB-KAWASUMI
- Medica Group
- Penney Medical
- Chengdu Ousai Medical
- Bain Medical
- Sanxin Medical
- Biolight
- Jafron
Key Questions Addressed in this Report
- What is the 10-year outlook for the global Blood Purification Cartridge market?
- What factors are driving Blood Purification Cartridge market growth, globally and by region?
- Which technologies are poised for the fastest growth by market and region?
- How do Blood Purification Cartridge market opportunities vary by end market size?
- How does Blood Purification Cartridge break out by Type, by Application?
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Purification Cartridge Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Blood Purification Cartridge by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Blood Purification Cartridge by Country/Region, 2021, 2025 & 2032
2.2 Blood Purification Cartridge Segment by Type
2.2.1 Hemodialyzer
2.2.2 Hemofilter
2.2.3 Hemoperfusion Cartridge
2.2.4 Other
2.2.5 Blood Purification Cartridge Sales by Type
2.2.5.1 Global Blood Purification Cartridge Sales Market Share by Type (2021-2026)
2.2.5.2 Global Blood Purification Cartridge Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Blood Purification Cartridge Sale Price by Type (2021-2026)
2.3 Blood Purification Cartridge Segment by Adsorption Selectivity
2.3.1 Broad-spectrum Adsorption Cartridges
2.3.2 Selective Adsorption Cartridges
2.3.3 Blood Purification Cartridge Sales by Adsorption Selectivity
2.3.3.1 Global Blood Purification Cartridge Sales Market Share by Adsorption Selectivity (2021-2026)
2.3.3.2 Global Blood Purification Cartridge Revenue and Market Share by Adsorption Selectivity (2021-2026)
2.3.3.3 Global Blood Purification Cartridge Sale Price by Adsorption Selectivity (2021-2026)
2.4 Blood Purification Cartridge Segment by Primary Target Substance
2.4.1 Uremic Toxin Adsorption Cartridges
2.4.2 Cytokine and Inflammatory Mediator Adsorption Cartridges
2.4.3 Endotoxin Adsorption Cartridges
2.4.4 Drug and Poison Adsorption Cartridges
2.4.5 Bilirubin and Liver Toxin Adsorption Cartridges
2.4.6 Other
2.4.7 Blood Purification Cartridge Sales by Primary Target Substance
2.4.7.1 Global Blood Purification Cartridge Sales Market Share by Primary Target Substance (2021-2026)
2.4.7.2 Global Blood Purification Cartridge Revenue and Market Share by Primary Target Substance (2021-2026)
2.4.7.3 Global Blood Purification Cartridge Sale Price by Primary Target Substance (2021-2026)
2.5 Blood Purification Cartridge Segment by Application
2.5.1 Hospital
2.5.2 Dialysis Center
2.5.3 Other
2.5.4 Blood Purification Cartridge Sales by Application
2.5.4.1 Global Blood Purification Cartridge Sale Market Share by Application (2021-2026)
2.5.4.2 Global Blood Purification Cartridge Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Blood Purification Cartridge Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Blood Purification Cartridge Breakdown Data by Company
3.1.1 Global Blood Purification Cartridge Annual Sales by Company (2021-2026)
3.1.2 Global Blood Purification Cartridge Sales Market Share by Company (2021-2026)
3.2 Global Blood Purification Cartridge Annual Revenue by Company (2021-2026)
3.2.1 Global Blood Purification Cartridge Revenue by Company (2021-2026)
3.2.2 Global Blood Purification Cartridge Revenue Market Share by Company (2021-2026)
3.3 Global Blood Purification Cartridge Sale Price by Company
3.4 Key Manufacturers Blood Purification Cartridge Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood Purification Cartridge Product Location Distribution
3.4.2 Players Blood Purification Cartridge Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BLOOD PURIFICATION CARTRIDGE BY GEOGRAPHIC REGION
4.1 World Historic Blood Purification Cartridge Market Size by Geographic Region (2021-2026)
4.1.1 Global Blood Purification Cartridge Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Blood Purification Cartridge Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Blood Purification Cartridge Market Size by Country/Region (2021-2026)
4.2.1 Global Blood Purification Cartridge Annual Sales by Country/Region (2021-2026)
4.2.2 Global Blood Purification Cartridge Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood Purification Cartridge Sales Growth
4.4 APAC Blood Purification Cartridge Sales Growth
4.5 Europe Blood Purification Cartridge Sales Growth
4.6 Middle East & Africa Blood Purification Cartridge Sales Growth
5 AMERICAS
5.1 Americas Blood Purification Cartridge Sales by Country
5.1.1 Americas Blood Purification Cartridge Sales by Country (2021-2026)
5.1.2 Americas Blood Purification Cartridge Revenue by Country (2021-2026)
5.2 Americas Blood Purification Cartridge Sales by Type (2021-2026)
5.3 Americas Blood Purification Cartridge Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Purification Cartridge Sales by Region
6.1.1 APAC Blood Purification Cartridge Sales by Region (2021-2026)
6.1.2 APAC Blood Purification Cartridge Revenue by Region (2021-2026)
6.2 APAC Blood Purification Cartridge Sales by Type (2021-2026)
6.3 APAC Blood Purification Cartridge Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Blood Purification Cartridge by Country
7.1.1 Europe Blood Purification Cartridge Sales by Country (2021-2026)
7.1.2 Europe Blood Purification Cartridge Revenue by Country (2021-2026)
7.2 Europe Blood Purification Cartridge Sales by Type (2021-2026)
7.3 Europe Blood Purification Cartridge Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Purification Cartridge by Country
8.1.1 Middle East & Africa Blood Purification Cartridge Sales by Country (2021-2026)
8.1.2 Middle East & Africa Blood Purification Cartridge Revenue by Country (2021-2026)
8.2 Middle East & Africa Blood Purification Cartridge Sales by Type (2021-2026)
8.3 Middle East & Africa Blood Purification Cartridge Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Purification Cartridge
10.3 Manufacturing Process Analysis of Blood Purification Cartridge
10.4 Industry Chain Structure of Blood Purification Cartridge
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood Purification Cartridge Distributors
11.3 Blood Purification Cartridge Customer
12 WORLD FORECAST REVIEW FOR BLOOD PURIFICATION CARTRIDGE BY GEOGRAPHIC REGION
12.1 Global Blood Purification Cartridge Market Size Forecast by Region
12.1.1 Global Blood Purification Cartridge Forecast by Region (2027-2032)
12.1.2 Global Blood Purification Cartridge Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Blood Purification Cartridge Forecast by Type (2027-2032)
12.7 Global Blood Purification Cartridge Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Fresenius
13.1.1 Fresenius Company Information
13.1.2 Fresenius Blood Purification Cartridge Product Portfolios and Specifications
13.1.3 Fresenius Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Fresenius Main Business Overview
13.1.5 Fresenius Latest Developments
13.2 Nikkiso
13.2.1 Nikkiso Company Information
13.2.2 Nikkiso Blood Purification Cartridge Product Portfolios and Specifications
13.2.3 Nikkiso Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Nikkiso Main Business Overview
13.2.5 Nikkiso Latest Developments
13.3 B. Braun
13.3.1 B. Braun Company Information
13.3.2 B. Braun Blood Purification Cartridge Product Portfolios and Specifications
13.3.3 B. Braun Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 B. Braun Main Business Overview
13.3.5 B. Braun Latest Developments
13.4 Baxter
13.4.1 Baxter Company Information
13.4.2 Baxter Blood Purification Cartridge Product Portfolios and Specifications
13.4.3 Baxter Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Baxter Main Business Overview
13.4.5 Baxter Latest Developments
13.5 Asahi Kasei
13.5.1 Asahi Kasei Company Information
13.5.2 Asahi Kasei Blood Purification Cartridge Product Portfolios and Specifications
13.5.3 Asahi Kasei Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Asahi Kasei Main Business Overview
13.5.5 Asahi Kasei Latest Developments
13.6 Nipro
13.6.1 Nipro Company Information
13.6.2 Nipro Blood Purification Cartridge Product Portfolios and Specifications
13.6.3 Nipro Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Nipro Main Business Overview
13.6.5 Nipro Latest Developments
13.7 Weigao Group
13.7.1 Weigao Group Company Information
13.7.2 Weigao Group Blood Purification Cartridge Product Portfolios and Specifications
13.7.3 Weigao Group Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Weigao Group Main Business Overview
13.7.5 Weigao Group Latest Developments
13.8 Toray
13.8.1 Toray Company Information
13.8.2 Toray Blood Purification Cartridge Product Portfolios and Specifications
13.8.3 Toray Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Toray Main Business Overview
13.8.5 Toray Latest Developments
13.9 Medtronic
13.9.1 Medtronic Company Information
13.9.2 Medtronic Blood Purification Cartridge Product Portfolios and Specifications
13.9.3 Medtronic Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Medtronic Main Business Overview
13.9.5 Medtronic Latest Developments
13.10 JMS
13.10.1 JMS Company Information
13.10.2 JMS Blood Purification Cartridge Product Portfolios and Specifications
13.10.3 JMS Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 JMS Main Business Overview
13.10.5 JMS Latest Developments
13.11 SB-KAWASUMI
13.11.1 SB-KAWASUMI Company Information
13.11.2 SB-KAWASUMI Blood Purification Cartridge Product Portfolios and Specifications
13.11.3 SB-KAWASUMI Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 SB-KAWASUMI Main Business Overview
13.11.5 SB-KAWASUMI Latest Developments
13.12 Medica Group
13.12.1 Medica Group Company Information
13.12.2 Medica Group Blood Purification Cartridge Product Portfolios and Specifications
13.12.3 Medica Group Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Medica Group Main Business Overview
13.12.5 Medica Group Latest Developments
13.13 Penney Medical
13.13.1 Penney Medical Company Information
13.13.2 Penney Medical Blood Purification Cartridge Product Portfolios and Specifications
13.13.3 Penney Medical Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Penney Medical Main Business Overview
13.13.5 Penney Medical Latest Developments
13.14 Chengdu Ousai Medical
13.14.1 Chengdu Ousai Medical Company Information
13.14.2 Chengdu Ousai Medical Blood Purification Cartridge Product Portfolios and Specifications
13.14.3 Chengdu Ousai Medical Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Chengdu Ousai Medical Main Business Overview
13.14.5 Chengdu Ousai Medical Latest Developments
13.15 Bain Medical
13.15.1 Bain Medical Company Information
13.15.2 Bain Medical Blood Purification Cartridge Product Portfolios and Specifications
13.15.3 Bain Medical Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Bain Medical Main Business Overview
13.15.5 Bain Medical Latest Developments
13.16 Sanxin Medical
13.16.1 Sanxin Medical Company Information
13.16.2 Sanxin Medical Blood Purification Cartridge Product Portfolios and Specifications
13.16.3 Sanxin Medical Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Sanxin Medical Main Business Overview
13.16.5 Sanxin Medical Latest Developments
13.17 Biolight
13.17.1 Biolight Company Information
13.17.2 Biolight Blood Purification Cartridge Product Portfolios and Specifications
13.17.3 Biolight Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Biolight Main Business Overview
13.17.5 Biolight Latest Developments
13.18 Jafron
13.18.1 Jafron Company Information
13.18.2 Jafron Blood Purification Cartridge Product Portfolios and Specifications
13.18.3 Jafron Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jafron Main Business Overview
13.18.5 Jafron Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Blood Purification Cartridge Annual Sales 2021-2032
2.1.2 World Current & Future Analysis for Blood Purification Cartridge by Geographic Region, 2021, 2025 & 2032
2.1.3 World Current & Future Analysis for Blood Purification Cartridge by Country/Region, 2021, 2025 & 2032
2.2 Blood Purification Cartridge Segment by Type
2.2.1 Hemodialyzer
2.2.2 Hemofilter
2.2.3 Hemoperfusion Cartridge
2.2.4 Other
2.2.5 Blood Purification Cartridge Sales by Type
2.2.5.1 Global Blood Purification Cartridge Sales Market Share by Type (2021-2026)
2.2.5.2 Global Blood Purification Cartridge Revenue and Market Share by Type (2021-2026)
2.2.5.3 Global Blood Purification Cartridge Sale Price by Type (2021-2026)
2.3 Blood Purification Cartridge Segment by Adsorption Selectivity
2.3.1 Broad-spectrum Adsorption Cartridges
2.3.2 Selective Adsorption Cartridges
2.3.3 Blood Purification Cartridge Sales by Adsorption Selectivity
2.3.3.1 Global Blood Purification Cartridge Sales Market Share by Adsorption Selectivity (2021-2026)
2.3.3.2 Global Blood Purification Cartridge Revenue and Market Share by Adsorption Selectivity (2021-2026)
2.3.3.3 Global Blood Purification Cartridge Sale Price by Adsorption Selectivity (2021-2026)
2.4 Blood Purification Cartridge Segment by Primary Target Substance
2.4.1 Uremic Toxin Adsorption Cartridges
2.4.2 Cytokine and Inflammatory Mediator Adsorption Cartridges
2.4.3 Endotoxin Adsorption Cartridges
2.4.4 Drug and Poison Adsorption Cartridges
2.4.5 Bilirubin and Liver Toxin Adsorption Cartridges
2.4.6 Other
2.4.7 Blood Purification Cartridge Sales by Primary Target Substance
2.4.7.1 Global Blood Purification Cartridge Sales Market Share by Primary Target Substance (2021-2026)
2.4.7.2 Global Blood Purification Cartridge Revenue and Market Share by Primary Target Substance (2021-2026)
2.4.7.3 Global Blood Purification Cartridge Sale Price by Primary Target Substance (2021-2026)
2.5 Blood Purification Cartridge Segment by Application
2.5.1 Hospital
2.5.2 Dialysis Center
2.5.3 Other
2.5.4 Blood Purification Cartridge Sales by Application
2.5.4.1 Global Blood Purification Cartridge Sale Market Share by Application (2021-2026)
2.5.4.2 Global Blood Purification Cartridge Revenue and Market Share by Application (2021-2026)
2.5.4.3 Global Blood Purification Cartridge Sale Price by Application (2021-2026)
3 GLOBAL BY COMPANY
3.1 Global Blood Purification Cartridge Breakdown Data by Company
3.1.1 Global Blood Purification Cartridge Annual Sales by Company (2021-2026)
3.1.2 Global Blood Purification Cartridge Sales Market Share by Company (2021-2026)
3.2 Global Blood Purification Cartridge Annual Revenue by Company (2021-2026)
3.2.1 Global Blood Purification Cartridge Revenue by Company (2021-2026)
3.2.2 Global Blood Purification Cartridge Revenue Market Share by Company (2021-2026)
3.3 Global Blood Purification Cartridge Sale Price by Company
3.4 Key Manufacturers Blood Purification Cartridge Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Blood Purification Cartridge Product Location Distribution
3.4.2 Players Blood Purification Cartridge Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.6 New Products and Potential Entrants
3.7 Market M&A Activity & Strategy
4 WORLD HISTORIC REVIEW FOR BLOOD PURIFICATION CARTRIDGE BY GEOGRAPHIC REGION
4.1 World Historic Blood Purification Cartridge Market Size by Geographic Region (2021-2026)
4.1.1 Global Blood Purification Cartridge Annual Sales by Geographic Region (2021-2026)
4.1.2 Global Blood Purification Cartridge Annual Revenue by Geographic Region (2021-2026)
4.2 World Historic Blood Purification Cartridge Market Size by Country/Region (2021-2026)
4.2.1 Global Blood Purification Cartridge Annual Sales by Country/Region (2021-2026)
4.2.2 Global Blood Purification Cartridge Annual Revenue by Country/Region (2021-2026)
4.3 Americas Blood Purification Cartridge Sales Growth
4.4 APAC Blood Purification Cartridge Sales Growth
4.5 Europe Blood Purification Cartridge Sales Growth
4.6 Middle East & Africa Blood Purification Cartridge Sales Growth
5 AMERICAS
5.1 Americas Blood Purification Cartridge Sales by Country
5.1.1 Americas Blood Purification Cartridge Sales by Country (2021-2026)
5.1.2 Americas Blood Purification Cartridge Revenue by Country (2021-2026)
5.2 Americas Blood Purification Cartridge Sales by Type (2021-2026)
5.3 Americas Blood Purification Cartridge Sales by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Blood Purification Cartridge Sales by Region
6.1.1 APAC Blood Purification Cartridge Sales by Region (2021-2026)
6.1.2 APAC Blood Purification Cartridge Revenue by Region (2021-2026)
6.2 APAC Blood Purification Cartridge Sales by Type (2021-2026)
6.3 APAC Blood Purification Cartridge Sales by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 EUROPE
7.1 Europe Blood Purification Cartridge by Country
7.1.1 Europe Blood Purification Cartridge Sales by Country (2021-2026)
7.1.2 Europe Blood Purification Cartridge Revenue by Country (2021-2026)
7.2 Europe Blood Purification Cartridge Sales by Type (2021-2026)
7.3 Europe Blood Purification Cartridge Sales by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Blood Purification Cartridge by Country
8.1.1 Middle East & Africa Blood Purification Cartridge Sales by Country (2021-2026)
8.1.2 Middle East & Africa Blood Purification Cartridge Revenue by Country (2021-2026)
8.2 Middle East & Africa Blood Purification Cartridge Sales by Type (2021-2026)
8.3 Middle East & Africa Blood Purification Cartridge Sales by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 MANUFACTURING COST STRUCTURE ANALYSIS
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Blood Purification Cartridge
10.3 Manufacturing Process Analysis of Blood Purification Cartridge
10.4 Industry Chain Structure of Blood Purification Cartridge
11 MARKETING, DISTRIBUTORS AND CUSTOMER
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Blood Purification Cartridge Distributors
11.3 Blood Purification Cartridge Customer
12 WORLD FORECAST REVIEW FOR BLOOD PURIFICATION CARTRIDGE BY GEOGRAPHIC REGION
12.1 Global Blood Purification Cartridge Market Size Forecast by Region
12.1.1 Global Blood Purification Cartridge Forecast by Region (2027-2032)
12.1.2 Global Blood Purification Cartridge Annual Revenue Forecast by Region (2027-2032)
12.2 Americas Forecast by Country (2027-2032)
12.3 APAC Forecast by Region (2027-2032)
12.4 Europe Forecast by Country (2027-2032)
12.5 Middle East & Africa Forecast by Country (2027-2032)
12.6 Global Blood Purification Cartridge Forecast by Type (2027-2032)
12.7 Global Blood Purification Cartridge Forecast by Application (2027-2032)
13 KEY PLAYERS ANALYSIS
13.1 Fresenius
13.1.1 Fresenius Company Information
13.1.2 Fresenius Blood Purification Cartridge Product Portfolios and Specifications
13.1.3 Fresenius Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.1.4 Fresenius Main Business Overview
13.1.5 Fresenius Latest Developments
13.2 Nikkiso
13.2.1 Nikkiso Company Information
13.2.2 Nikkiso Blood Purification Cartridge Product Portfolios and Specifications
13.2.3 Nikkiso Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.2.4 Nikkiso Main Business Overview
13.2.5 Nikkiso Latest Developments
13.3 B. Braun
13.3.1 B. Braun Company Information
13.3.2 B. Braun Blood Purification Cartridge Product Portfolios and Specifications
13.3.3 B. Braun Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.3.4 B. Braun Main Business Overview
13.3.5 B. Braun Latest Developments
13.4 Baxter
13.4.1 Baxter Company Information
13.4.2 Baxter Blood Purification Cartridge Product Portfolios and Specifications
13.4.3 Baxter Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.4.4 Baxter Main Business Overview
13.4.5 Baxter Latest Developments
13.5 Asahi Kasei
13.5.1 Asahi Kasei Company Information
13.5.2 Asahi Kasei Blood Purification Cartridge Product Portfolios and Specifications
13.5.3 Asahi Kasei Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.5.4 Asahi Kasei Main Business Overview
13.5.5 Asahi Kasei Latest Developments
13.6 Nipro
13.6.1 Nipro Company Information
13.6.2 Nipro Blood Purification Cartridge Product Portfolios and Specifications
13.6.3 Nipro Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.6.4 Nipro Main Business Overview
13.6.5 Nipro Latest Developments
13.7 Weigao Group
13.7.1 Weigao Group Company Information
13.7.2 Weigao Group Blood Purification Cartridge Product Portfolios and Specifications
13.7.3 Weigao Group Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.7.4 Weigao Group Main Business Overview
13.7.5 Weigao Group Latest Developments
13.8 Toray
13.8.1 Toray Company Information
13.8.2 Toray Blood Purification Cartridge Product Portfolios and Specifications
13.8.3 Toray Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.8.4 Toray Main Business Overview
13.8.5 Toray Latest Developments
13.9 Medtronic
13.9.1 Medtronic Company Information
13.9.2 Medtronic Blood Purification Cartridge Product Portfolios and Specifications
13.9.3 Medtronic Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.9.4 Medtronic Main Business Overview
13.9.5 Medtronic Latest Developments
13.10 JMS
13.10.1 JMS Company Information
13.10.2 JMS Blood Purification Cartridge Product Portfolios and Specifications
13.10.3 JMS Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.10.4 JMS Main Business Overview
13.10.5 JMS Latest Developments
13.11 SB-KAWASUMI
13.11.1 SB-KAWASUMI Company Information
13.11.2 SB-KAWASUMI Blood Purification Cartridge Product Portfolios and Specifications
13.11.3 SB-KAWASUMI Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.11.4 SB-KAWASUMI Main Business Overview
13.11.5 SB-KAWASUMI Latest Developments
13.12 Medica Group
13.12.1 Medica Group Company Information
13.12.2 Medica Group Blood Purification Cartridge Product Portfolios and Specifications
13.12.3 Medica Group Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.12.4 Medica Group Main Business Overview
13.12.5 Medica Group Latest Developments
13.13 Penney Medical
13.13.1 Penney Medical Company Information
13.13.2 Penney Medical Blood Purification Cartridge Product Portfolios and Specifications
13.13.3 Penney Medical Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.13.4 Penney Medical Main Business Overview
13.13.5 Penney Medical Latest Developments
13.14 Chengdu Ousai Medical
13.14.1 Chengdu Ousai Medical Company Information
13.14.2 Chengdu Ousai Medical Blood Purification Cartridge Product Portfolios and Specifications
13.14.3 Chengdu Ousai Medical Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.14.4 Chengdu Ousai Medical Main Business Overview
13.14.5 Chengdu Ousai Medical Latest Developments
13.15 Bain Medical
13.15.1 Bain Medical Company Information
13.15.2 Bain Medical Blood Purification Cartridge Product Portfolios and Specifications
13.15.3 Bain Medical Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.15.4 Bain Medical Main Business Overview
13.15.5 Bain Medical Latest Developments
13.16 Sanxin Medical
13.16.1 Sanxin Medical Company Information
13.16.2 Sanxin Medical Blood Purification Cartridge Product Portfolios and Specifications
13.16.3 Sanxin Medical Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.16.4 Sanxin Medical Main Business Overview
13.16.5 Sanxin Medical Latest Developments
13.17 Biolight
13.17.1 Biolight Company Information
13.17.2 Biolight Blood Purification Cartridge Product Portfolios and Specifications
13.17.3 Biolight Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.17.4 Biolight Main Business Overview
13.17.5 Biolight Latest Developments
13.18 Jafron
13.18.1 Jafron Company Information
13.18.2 Jafron Blood Purification Cartridge Product Portfolios and Specifications
13.18.3 Jafron Blood Purification Cartridge Sales, Revenue, Price and Gross Margin (2021-2026)
13.18.4 Jafron Main Business Overview
13.18.5 Jafron Latest Developments
14 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Blood Purification Cartridge Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Blood Purification Cartridge Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Hemodialyzer
Table 4. Major Players of Hemofilter
Table 5. Major Players of Hemoperfusion Cartridge
Table 6. Major Players of Other
Table 7. Global Blood Purification Cartridge Sales by Type (2021-2026) & (K Units)
Table 8. Global Blood Purification Cartridge Sales Market Share by Type (2021-2026)
Table 9. Global Blood Purification Cartridge Revenue by Type (2021-2026) & ($ million)
Table 10. Global Blood Purification Cartridge Revenue Market Share by Type (2021-2026)
Table 11. Global Blood Purification Cartridge Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Broad-spectrum Adsorption Cartridges
Table 13. Major Players of Selective Adsorption Cartridges
Table 14. Global Blood Purification Cartridge Sales by Adsorption Selectivity (2021-2026) & (K Units)
Table 15. Global Blood Purification Cartridge Sales Market Share by Adsorption Selectivity (2021-2026)
Table 16. Global Blood Purification Cartridge Revenue by Adsorption Selectivity (2021-2026) & ($ million)
Table 17. Global Blood Purification Cartridge Revenue Market Share by Adsorption Selectivity (2021-2026)
Table 18. Global Blood Purification Cartridge Sale Price by Adsorption Selectivity (2021-2026) & (US$/Unit)
Table 19. Major Players of Uremic Toxin Adsorption Cartridges
Table 20. Major Players of Cytokine and Inflammatory Mediator Adsorption Cartridges
Table 21. Major Players of Endotoxin Adsorption Cartridges
Table 22. Major Players of Drug and Poison Adsorption Cartridges
Table 23. Major Players of Bilirubin and Liver Toxin Adsorption Cartridges
Table 24. Major Players of Other
Table 25. Global Blood Purification Cartridge Sales by Primary Target Substance (2021-2026) & (K Units)
Table 26. Global Blood Purification Cartridge Sales Market Share by Primary Target Substance (2021-2026)
Table 27. Global Blood Purification Cartridge Revenue by Primary Target Substance (2021-2026) & ($ million)
Table 28. Global Blood Purification Cartridge Revenue Market Share by Primary Target Substance (2021-2026)
Table 29. Global Blood Purification Cartridge Sale Price by Primary Target Substance (2021-2026) & (US$/Unit)
Table 30. Global Blood Purification Cartridge Sale by Application (2021-2026) & (K Units)
Table 31. Global Blood Purification Cartridge Sale Market Share by Application (2021-2026)
Table 32. Global Blood Purification Cartridge Revenue by Application (2021-2026) & ($ million)
Table 33. Global Blood Purification Cartridge Revenue Market Share by Application (2021-2026)
Table 34. Global Blood Purification Cartridge Sale Price by Application (2021-2026) & (US$/Unit)
Table 35. Global Blood Purification Cartridge Sales by Company (2021-2026) & (K Units)
Table 36. Global Blood Purification Cartridge Sales Market Share by Company (2021-2026)
Table 37. Global Blood Purification Cartridge Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Blood Purification Cartridge Revenue Market Share by Company (2021-2026)
Table 39. Global Blood Purification Cartridge Sale Price by Company (2021-2026) & (US$/Unit)
Table 40. Key Manufacturers Blood Purification Cartridge Producing Area Distribution and Sales Area
Table 41. Players Blood Purification Cartridge Products Offered
Table 42. Blood Purification Cartridge Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Blood Purification Cartridge Sales by Geographic Region (2021-2026) & (K Units)
Table 46. Global Blood Purification Cartridge Sales Market Share Geographic Region (2021-2026)
Table 47. Global Blood Purification Cartridge Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Blood Purification Cartridge Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Blood Purification Cartridge Sales by Country/Region (2021-2026) & (K Units)
Table 50. Global Blood Purification Cartridge Sales Market Share by Country/Region (2021-2026)
Table 51. Global Blood Purification Cartridge Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Blood Purification Cartridge Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Blood Purification Cartridge Sales by Country (2021-2026) & (K Units)
Table 54. Americas Blood Purification Cartridge Sales Market Share by Country (2021-2026)
Table 55. Americas Blood Purification Cartridge Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Blood Purification Cartridge Sales by Type (2021-2026) & (K Units)
Table 57. Americas Blood Purification Cartridge Sales by Application (2021-2026) & (K Units)
Table 58. APAC Blood Purification Cartridge Sales by Region (2021-2026) & (K Units)
Table 59. APAC Blood Purification Cartridge Sales Market Share by Region (2021-2026)
Table 60. APAC Blood Purification Cartridge Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Blood Purification Cartridge Sales by Type (2021-2026) & (K Units)
Table 62. APAC Blood Purification Cartridge Sales by Application (2021-2026) & (K Units)
Table 63. Europe Blood Purification Cartridge Sales by Country (2021-2026) & (K Units)
Table 64. Europe Blood Purification Cartridge Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Blood Purification Cartridge Sales by Type (2021-2026) & (K Units)
Table 66. Europe Blood Purification Cartridge Sales by Application (2021-2026) & (K Units)
Table 67. Middle East & Africa Blood Purification Cartridge Sales by Country (2021-2026) & (K Units)
Table 68. Middle East & Africa Blood Purification Cartridge Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Blood Purification Cartridge Sales by Type (2021-2026) & (K Units)
Table 70. Middle East & Africa Blood Purification Cartridge Sales by Application (2021-2026) & (K Units)
Table 71. Key Market Drivers & Growth Opportunities of Blood Purification Cartridge
Table 72. Key Market Challenges & Risks of Blood Purification Cartridge
Table 73. Key Industry Trends of Blood Purification Cartridge
Table 74. Blood Purification Cartridge Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Blood Purification Cartridge Distributors List
Table 77. Blood Purification Cartridge Customer List
Table 78. Global Blood Purification Cartridge Sales Forecast by Region (2027-2032) & (K Units)
Table 79. Global Blood Purification Cartridge Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Blood Purification Cartridge Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Americas Blood Purification Cartridge Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Blood Purification Cartridge Sales Forecast by Region (2027-2032) & (K Units)
Table 83. APAC Blood Purification Cartridge Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Blood Purification Cartridge Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Europe Blood Purification Cartridge Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Blood Purification Cartridge Sales Forecast by Country (2027-2032) & (K Units)
Table 87. Middle East & Africa Blood Purification Cartridge Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Blood Purification Cartridge Sales Forecast by Type (2027-2032) & (K Units)
Table 89. Global Blood Purification Cartridge Revenue Forecast by Type (2027-2032) & ($ millions)
Table 90. Global Blood Purification Cartridge Sales Forecast by Application (2027-2032) & (K Units)
Table 91. Global Blood Purification Cartridge Revenue Forecast by Application (2027-2032) & ($ millions)
Table 92. Fresenius Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 93. Fresenius Blood Purification Cartridge Product Portfolios and Specifications
Table 94. Fresenius Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Fresenius Main Business
Table 96. Fresenius Latest Developments
Table 97. Nikkiso Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 98. Nikkiso Blood Purification Cartridge Product Portfolios and Specifications
Table 99. Nikkiso Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Nikkiso Main Business
Table 101. Nikkiso Latest Developments
Table 102. B. Braun Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 103. B. Braun Blood Purification Cartridge Product Portfolios and Specifications
Table 104. B. Braun Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. B. Braun Main Business
Table 106. B. Braun Latest Developments
Table 107. Baxter Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 108. Baxter Blood Purification Cartridge Product Portfolios and Specifications
Table 109. Baxter Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Baxter Main Business
Table 111. Baxter Latest Developments
Table 112. Asahi Kasei Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 113. Asahi Kasei Blood Purification Cartridge Product Portfolios and Specifications
Table 114. Asahi Kasei Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Asahi Kasei Main Business
Table 116. Asahi Kasei Latest Developments
Table 117. Nipro Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 118. Nipro Blood Purification Cartridge Product Portfolios and Specifications
Table 119. Nipro Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Nipro Main Business
Table 121. Nipro Latest Developments
Table 122. Weigao Group Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 123. Weigao Group Blood Purification Cartridge Product Portfolios and Specifications
Table 124. Weigao Group Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Weigao Group Main Business
Table 126. Weigao Group Latest Developments
Table 127. Toray Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 128. Toray Blood Purification Cartridge Product Portfolios and Specifications
Table 129. Toray Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Toray Main Business
Table 131. Toray Latest Developments
Table 132. Medtronic Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 133. Medtronic Blood Purification Cartridge Product Portfolios and Specifications
Table 134. Medtronic Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Medtronic Main Business
Table 136. Medtronic Latest Developments
Table 137. JMS Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 138. JMS Blood Purification Cartridge Product Portfolios and Specifications
Table 139. JMS Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. JMS Main Business
Table 141. JMS Latest Developments
Table 142. SB-KAWASUMI Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 143. SB-KAWASUMI Blood Purification Cartridge Product Portfolios and Specifications
Table 144. SB-KAWASUMI Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. SB-KAWASUMI Main Business
Table 146. SB-KAWASUMI Latest Developments
Table 147. Medica Group Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 148. Medica Group Blood Purification Cartridge Product Portfolios and Specifications
Table 149. Medica Group Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Medica Group Main Business
Table 151. Medica Group Latest Developments
Table 152. Penney Medical Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 153. Penney Medical Blood Purification Cartridge Product Portfolios and Specifications
Table 154. Penney Medical Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Penney Medical Main Business
Table 156. Penney Medical Latest Developments
Table 157. Chengdu Ousai Medical Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 158. Chengdu Ousai Medical Blood Purification Cartridge Product Portfolios and Specifications
Table 159. Chengdu Ousai Medical Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Chengdu Ousai Medical Main Business
Table 161. Chengdu Ousai Medical Latest Developments
Table 162. Bain Medical Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 163. Bain Medical Blood Purification Cartridge Product Portfolios and Specifications
Table 164. Bain Medical Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Bain Medical Main Business
Table 166. Bain Medical Latest Developments
Table 167. Sanxin Medical Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 168. Sanxin Medical Blood Purification Cartridge Product Portfolios and Specifications
Table 169. Sanxin Medical Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Sanxin Medical Main Business
Table 171. Sanxin Medical Latest Developments
Table 172. Biolight Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 173. Biolight Blood Purification Cartridge Product Portfolios and Specifications
Table 174. Biolight Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. Biolight Main Business
Table 176. Biolight Latest Developments
Table 177. Jafron Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 178. Jafron Blood Purification Cartridge Product Portfolios and Specifications
Table 179. Jafron Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Jafron Main Business
Table 181. Jafron Latest Developments
Table 1. Blood Purification Cartridge Annual Sales CAGR by Geographic Region (2021, 2025 & 2032) & ($ millions)
Table 2. Blood Purification Cartridge Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Hemodialyzer
Table 4. Major Players of Hemofilter
Table 5. Major Players of Hemoperfusion Cartridge
Table 6. Major Players of Other
Table 7. Global Blood Purification Cartridge Sales by Type (2021-2026) & (K Units)
Table 8. Global Blood Purification Cartridge Sales Market Share by Type (2021-2026)
Table 9. Global Blood Purification Cartridge Revenue by Type (2021-2026) & ($ million)
Table 10. Global Blood Purification Cartridge Revenue Market Share by Type (2021-2026)
Table 11. Global Blood Purification Cartridge Sale Price by Type (2021-2026) & (US$/Unit)
Table 12. Major Players of Broad-spectrum Adsorption Cartridges
Table 13. Major Players of Selective Adsorption Cartridges
Table 14. Global Blood Purification Cartridge Sales by Adsorption Selectivity (2021-2026) & (K Units)
Table 15. Global Blood Purification Cartridge Sales Market Share by Adsorption Selectivity (2021-2026)
Table 16. Global Blood Purification Cartridge Revenue by Adsorption Selectivity (2021-2026) & ($ million)
Table 17. Global Blood Purification Cartridge Revenue Market Share by Adsorption Selectivity (2021-2026)
Table 18. Global Blood Purification Cartridge Sale Price by Adsorption Selectivity (2021-2026) & (US$/Unit)
Table 19. Major Players of Uremic Toxin Adsorption Cartridges
Table 20. Major Players of Cytokine and Inflammatory Mediator Adsorption Cartridges
Table 21. Major Players of Endotoxin Adsorption Cartridges
Table 22. Major Players of Drug and Poison Adsorption Cartridges
Table 23. Major Players of Bilirubin and Liver Toxin Adsorption Cartridges
Table 24. Major Players of Other
Table 25. Global Blood Purification Cartridge Sales by Primary Target Substance (2021-2026) & (K Units)
Table 26. Global Blood Purification Cartridge Sales Market Share by Primary Target Substance (2021-2026)
Table 27. Global Blood Purification Cartridge Revenue by Primary Target Substance (2021-2026) & ($ million)
Table 28. Global Blood Purification Cartridge Revenue Market Share by Primary Target Substance (2021-2026)
Table 29. Global Blood Purification Cartridge Sale Price by Primary Target Substance (2021-2026) & (US$/Unit)
Table 30. Global Blood Purification Cartridge Sale by Application (2021-2026) & (K Units)
Table 31. Global Blood Purification Cartridge Sale Market Share by Application (2021-2026)
Table 32. Global Blood Purification Cartridge Revenue by Application (2021-2026) & ($ million)
Table 33. Global Blood Purification Cartridge Revenue Market Share by Application (2021-2026)
Table 34. Global Blood Purification Cartridge Sale Price by Application (2021-2026) & (US$/Unit)
Table 35. Global Blood Purification Cartridge Sales by Company (2021-2026) & (K Units)
Table 36. Global Blood Purification Cartridge Sales Market Share by Company (2021-2026)
Table 37. Global Blood Purification Cartridge Revenue by Company (2021-2026) & ($ millions)
Table 38. Global Blood Purification Cartridge Revenue Market Share by Company (2021-2026)
Table 39. Global Blood Purification Cartridge Sale Price by Company (2021-2026) & (US$/Unit)
Table 40. Key Manufacturers Blood Purification Cartridge Producing Area Distribution and Sales Area
Table 41. Players Blood Purification Cartridge Products Offered
Table 42. Blood Purification Cartridge Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 43. New Products and Potential Entrants
Table 44. Market M&A Activity & Strategy
Table 45. Global Blood Purification Cartridge Sales by Geographic Region (2021-2026) & (K Units)
Table 46. Global Blood Purification Cartridge Sales Market Share Geographic Region (2021-2026)
Table 47. Global Blood Purification Cartridge Revenue by Geographic Region (2021-2026) & ($ millions)
Table 48. Global Blood Purification Cartridge Revenue Market Share by Geographic Region (2021-2026)
Table 49. Global Blood Purification Cartridge Sales by Country/Region (2021-2026) & (K Units)
Table 50. Global Blood Purification Cartridge Sales Market Share by Country/Region (2021-2026)
Table 51. Global Blood Purification Cartridge Revenue by Country/Region (2021-2026) & ($ millions)
Table 52. Global Blood Purification Cartridge Revenue Market Share by Country/Region (2021-2026)
Table 53. Americas Blood Purification Cartridge Sales by Country (2021-2026) & (K Units)
Table 54. Americas Blood Purification Cartridge Sales Market Share by Country (2021-2026)
Table 55. Americas Blood Purification Cartridge Revenue by Country (2021-2026) & ($ millions)
Table 56. Americas Blood Purification Cartridge Sales by Type (2021-2026) & (K Units)
Table 57. Americas Blood Purification Cartridge Sales by Application (2021-2026) & (K Units)
Table 58. APAC Blood Purification Cartridge Sales by Region (2021-2026) & (K Units)
Table 59. APAC Blood Purification Cartridge Sales Market Share by Region (2021-2026)
Table 60. APAC Blood Purification Cartridge Revenue by Region (2021-2026) & ($ millions)
Table 61. APAC Blood Purification Cartridge Sales by Type (2021-2026) & (K Units)
Table 62. APAC Blood Purification Cartridge Sales by Application (2021-2026) & (K Units)
Table 63. Europe Blood Purification Cartridge Sales by Country (2021-2026) & (K Units)
Table 64. Europe Blood Purification Cartridge Revenue by Country (2021-2026) & ($ millions)
Table 65. Europe Blood Purification Cartridge Sales by Type (2021-2026) & (K Units)
Table 66. Europe Blood Purification Cartridge Sales by Application (2021-2026) & (K Units)
Table 67. Middle East & Africa Blood Purification Cartridge Sales by Country (2021-2026) & (K Units)
Table 68. Middle East & Africa Blood Purification Cartridge Revenue Market Share by Country (2021-2026)
Table 69. Middle East & Africa Blood Purification Cartridge Sales by Type (2021-2026) & (K Units)
Table 70. Middle East & Africa Blood Purification Cartridge Sales by Application (2021-2026) & (K Units)
Table 71. Key Market Drivers & Growth Opportunities of Blood Purification Cartridge
Table 72. Key Market Challenges & Risks of Blood Purification Cartridge
Table 73. Key Industry Trends of Blood Purification Cartridge
Table 74. Blood Purification Cartridge Raw Material
Table 75. Key Suppliers of Raw Materials
Table 76. Blood Purification Cartridge Distributors List
Table 77. Blood Purification Cartridge Customer List
Table 78. Global Blood Purification Cartridge Sales Forecast by Region (2027-2032) & (K Units)
Table 79. Global Blood Purification Cartridge Revenue Forecast by Region (2027-2032) & ($ millions)
Table 80. Americas Blood Purification Cartridge Sales Forecast by Country (2027-2032) & (K Units)
Table 81. Americas Blood Purification Cartridge Annual Revenue Forecast by Country (2027-2032) & ($ millions)
Table 82. APAC Blood Purification Cartridge Sales Forecast by Region (2027-2032) & (K Units)
Table 83. APAC Blood Purification Cartridge Annual Revenue Forecast by Region (2027-2032) & ($ millions)
Table 84. Europe Blood Purification Cartridge Sales Forecast by Country (2027-2032) & (K Units)
Table 85. Europe Blood Purification Cartridge Revenue Forecast by Country (2027-2032) & ($ millions)
Table 86. Middle East & Africa Blood Purification Cartridge Sales Forecast by Country (2027-2032) & (K Units)
Table 87. Middle East & Africa Blood Purification Cartridge Revenue Forecast by Country (2027-2032) & ($ millions)
Table 88. Global Blood Purification Cartridge Sales Forecast by Type (2027-2032) & (K Units)
Table 89. Global Blood Purification Cartridge Revenue Forecast by Type (2027-2032) & ($ millions)
Table 90. Global Blood Purification Cartridge Sales Forecast by Application (2027-2032) & (K Units)
Table 91. Global Blood Purification Cartridge Revenue Forecast by Application (2027-2032) & ($ millions)
Table 92. Fresenius Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 93. Fresenius Blood Purification Cartridge Product Portfolios and Specifications
Table 94. Fresenius Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 95. Fresenius Main Business
Table 96. Fresenius Latest Developments
Table 97. Nikkiso Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 98. Nikkiso Blood Purification Cartridge Product Portfolios and Specifications
Table 99. Nikkiso Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 100. Nikkiso Main Business
Table 101. Nikkiso Latest Developments
Table 102. B. Braun Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 103. B. Braun Blood Purification Cartridge Product Portfolios and Specifications
Table 104. B. Braun Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 105. B. Braun Main Business
Table 106. B. Braun Latest Developments
Table 107. Baxter Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 108. Baxter Blood Purification Cartridge Product Portfolios and Specifications
Table 109. Baxter Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 110. Baxter Main Business
Table 111. Baxter Latest Developments
Table 112. Asahi Kasei Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 113. Asahi Kasei Blood Purification Cartridge Product Portfolios and Specifications
Table 114. Asahi Kasei Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 115. Asahi Kasei Main Business
Table 116. Asahi Kasei Latest Developments
Table 117. Nipro Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 118. Nipro Blood Purification Cartridge Product Portfolios and Specifications
Table 119. Nipro Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 120. Nipro Main Business
Table 121. Nipro Latest Developments
Table 122. Weigao Group Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 123. Weigao Group Blood Purification Cartridge Product Portfolios and Specifications
Table 124. Weigao Group Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 125. Weigao Group Main Business
Table 126. Weigao Group Latest Developments
Table 127. Toray Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 128. Toray Blood Purification Cartridge Product Portfolios and Specifications
Table 129. Toray Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 130. Toray Main Business
Table 131. Toray Latest Developments
Table 132. Medtronic Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 133. Medtronic Blood Purification Cartridge Product Portfolios and Specifications
Table 134. Medtronic Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 135. Medtronic Main Business
Table 136. Medtronic Latest Developments
Table 137. JMS Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 138. JMS Blood Purification Cartridge Product Portfolios and Specifications
Table 139. JMS Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 140. JMS Main Business
Table 141. JMS Latest Developments
Table 142. SB-KAWASUMI Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 143. SB-KAWASUMI Blood Purification Cartridge Product Portfolios and Specifications
Table 144. SB-KAWASUMI Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 145. SB-KAWASUMI Main Business
Table 146. SB-KAWASUMI Latest Developments
Table 147. Medica Group Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 148. Medica Group Blood Purification Cartridge Product Portfolios and Specifications
Table 149. Medica Group Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 150. Medica Group Main Business
Table 151. Medica Group Latest Developments
Table 152. Penney Medical Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 153. Penney Medical Blood Purification Cartridge Product Portfolios and Specifications
Table 154. Penney Medical Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 155. Penney Medical Main Business
Table 156. Penney Medical Latest Developments
Table 157. Chengdu Ousai Medical Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 158. Chengdu Ousai Medical Blood Purification Cartridge Product Portfolios and Specifications
Table 159. Chengdu Ousai Medical Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 160. Chengdu Ousai Medical Main Business
Table 161. Chengdu Ousai Medical Latest Developments
Table 162. Bain Medical Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 163. Bain Medical Blood Purification Cartridge Product Portfolios and Specifications
Table 164. Bain Medical Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 165. Bain Medical Main Business
Table 166. Bain Medical Latest Developments
Table 167. Sanxin Medical Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 168. Sanxin Medical Blood Purification Cartridge Product Portfolios and Specifications
Table 169. Sanxin Medical Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 170. Sanxin Medical Main Business
Table 171. Sanxin Medical Latest Developments
Table 172. Biolight Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 173. Biolight Blood Purification Cartridge Product Portfolios and Specifications
Table 174. Biolight Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 175. Biolight Main Business
Table 176. Biolight Latest Developments
Table 177. Jafron Basic Information, Blood Purification Cartridge Manufacturing Base, Sales Area and Its Competitors
Table 178. Jafron Blood Purification Cartridge Product Portfolios and Specifications
Table 179. Jafron Blood Purification Cartridge Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2021-2026)
Table 180. Jafron Main Business
Table 181. Jafron Latest Developments
LIST OF FIGURES
Figure 1. Picture of Blood Purification Cartridge
Figure 2. Blood Purification Cartridge Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Purification Cartridge Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Blood Purification Cartridge Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Blood Purification Cartridge Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Blood Purification Cartridge Sales Market Share by Country/Region (2025)
Figure 10. Blood Purification Cartridge Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Hemodialyzer
Figure 12. Product Picture of Hemofilter
Figure 13. Product Picture of Hemoperfusion Cartridge
Figure 14. Product Picture of Other
Figure 15. Global Blood Purification Cartridge Sales Market Share by Type in 2026
Figure 16. Global Blood Purification Cartridge Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Broad-spectrum Adsorption Cartridges
Figure 18. Product Picture of Selective Adsorption Cartridges
Figure 19. Global Blood Purification Cartridge Sales Market Share by Adsorption Selectivity in 2026
Figure 20. Global Blood Purification Cartridge Revenue Market Share by Adsorption Selectivity (2021-2026)
Figure 21. Product Picture of Uremic Toxin Adsorption Cartridges
Figure 22. Product Picture of Cytokine and Inflammatory Mediator Adsorption Cartridges
Figure 23. Product Picture of Endotoxin Adsorption Cartridges
Figure 24. Product Picture of Drug and Poison Adsorption Cartridges
Figure 25. Product Picture of Bilirubin and Liver Toxin Adsorption Cartridges
Figure 26. Product Picture of Other
Figure 27. Global Blood Purification Cartridge Sales Market Share by Primary Target Substance in 2026
Figure 28. Global Blood Purification Cartridge Revenue Market Share by Primary Target Substance (2021-2026)
Figure 29. Blood Purification Cartridge Consumed in Hospital
Figure 30. Global Blood Purification Cartridge Market: Hospital (2021-2026) & (K Units)
Figure 31. Blood Purification Cartridge Consumed in Dialysis Center
Figure 32. Global Blood Purification Cartridge Market: Dialysis Center (2021-2026) & (K Units)
Figure 33. Blood Purification Cartridge Consumed in Other
Figure 34. Global Blood Purification Cartridge Market: Other (2021-2026) & (K Units)
Figure 35. Global Blood Purification Cartridge Sale Market Share by Application (2025)
Figure 36. Global Blood Purification Cartridge Revenue Market Share by Application in 2025
Figure 37. Blood Purification Cartridge Sales by Company in 2025 (K Units)
Figure 38. Global Blood Purification Cartridge Sales Market Share by Company in 2025
Figure 39. Blood Purification Cartridge Revenue by Company in 2025 ($ millions)
Figure 40. Global Blood Purification Cartridge Revenue Market Share by Company in 2025
Figure 41. Global Blood Purification Cartridge Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Blood Purification Cartridge Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Blood Purification Cartridge Sales 2021-2026 (K Units)
Figure 44. Americas Blood Purification Cartridge Revenue 2021-2026 ($ millions)
Figure 45. APAC Blood Purification Cartridge Sales 2021-2026 (K Units)
Figure 46. APAC Blood Purification Cartridge Revenue 2021-2026 ($ millions)
Figure 47. Europe Blood Purification Cartridge Sales 2021-2026 (K Units)
Figure 48. Europe Blood Purification Cartridge Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Blood Purification Cartridge Sales 2021-2026 (K Units)
Figure 50. Middle East & Africa Blood Purification Cartridge Revenue 2021-2026 ($ millions)
Figure 51. Americas Blood Purification Cartridge Sales Market Share by Country in 2025
Figure 52. Americas Blood Purification Cartridge Revenue Market Share by Country (2021-2026)
Figure 53. Americas Blood Purification Cartridge Sales Market Share by Type (2021-2026)
Figure 54. Americas Blood Purification Cartridge Sales Market Share by Application (2021-2026)
Figure 55. United States Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Blood Purification Cartridge Sales Market Share by Region in 2025
Figure 60. APAC Blood Purification Cartridge Revenue Market Share by Region (2021-2026)
Figure 61. APAC Blood Purification Cartridge Sales Market Share by Type (2021-2026)
Figure 62. APAC Blood Purification Cartridge Sales Market Share by Application (2021-2026)
Figure 63. China Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 67. India Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Blood Purification Cartridge Sales Market Share by Country in 2025
Figure 71. Europe Blood Purification Cartridge Revenue Market Share by Country (2021-2026)
Figure 72. Europe Blood Purification Cartridge Sales Market Share by Type (2021-2026)
Figure 73. Europe Blood Purification Cartridge Sales Market Share by Application (2021-2026)
Figure 74. Germany Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 75. France Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Blood Purification Cartridge Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Blood Purification Cartridge Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Blood Purification Cartridge Sales Market Share by Application (2021-2026)
Figure 82. Egypt Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Blood Purification Cartridge in 2026
Figure 88. Manufacturing Process Analysis of Blood Purification Cartridge
Figure 89. Industry Chain Structure of Blood Purification Cartridge
Figure 90. Channels of Distribution
Figure 91. Global Blood Purification Cartridge Sales Market Forecast by Region (2027-2032)
Figure 92. Global Blood Purification Cartridge Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Blood Purification Cartridge Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Blood Purification Cartridge Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Blood Purification Cartridge Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Blood Purification Cartridge Revenue Market Share Forecast by Application (2027-2032)
Figure 1. Picture of Blood Purification Cartridge
Figure 2. Blood Purification Cartridge Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Blood Purification Cartridge Sales Growth Rate 2021-2032 (K Units)
Figure 7. Global Blood Purification Cartridge Revenue Growth Rate 2021-2032 ($ millions)
Figure 8. Blood Purification Cartridge Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 9. Blood Purification Cartridge Sales Market Share by Country/Region (2025)
Figure 10. Blood Purification Cartridge Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 11. Product Picture of Hemodialyzer
Figure 12. Product Picture of Hemofilter
Figure 13. Product Picture of Hemoperfusion Cartridge
Figure 14. Product Picture of Other
Figure 15. Global Blood Purification Cartridge Sales Market Share by Type in 2026
Figure 16. Global Blood Purification Cartridge Revenue Market Share by Type (2021-2026)
Figure 17. Product Picture of Broad-spectrum Adsorption Cartridges
Figure 18. Product Picture of Selective Adsorption Cartridges
Figure 19. Global Blood Purification Cartridge Sales Market Share by Adsorption Selectivity in 2026
Figure 20. Global Blood Purification Cartridge Revenue Market Share by Adsorption Selectivity (2021-2026)
Figure 21. Product Picture of Uremic Toxin Adsorption Cartridges
Figure 22. Product Picture of Cytokine and Inflammatory Mediator Adsorption Cartridges
Figure 23. Product Picture of Endotoxin Adsorption Cartridges
Figure 24. Product Picture of Drug and Poison Adsorption Cartridges
Figure 25. Product Picture of Bilirubin and Liver Toxin Adsorption Cartridges
Figure 26. Product Picture of Other
Figure 27. Global Blood Purification Cartridge Sales Market Share by Primary Target Substance in 2026
Figure 28. Global Blood Purification Cartridge Revenue Market Share by Primary Target Substance (2021-2026)
Figure 29. Blood Purification Cartridge Consumed in Hospital
Figure 30. Global Blood Purification Cartridge Market: Hospital (2021-2026) & (K Units)
Figure 31. Blood Purification Cartridge Consumed in Dialysis Center
Figure 32. Global Blood Purification Cartridge Market: Dialysis Center (2021-2026) & (K Units)
Figure 33. Blood Purification Cartridge Consumed in Other
Figure 34. Global Blood Purification Cartridge Market: Other (2021-2026) & (K Units)
Figure 35. Global Blood Purification Cartridge Sale Market Share by Application (2025)
Figure 36. Global Blood Purification Cartridge Revenue Market Share by Application in 2025
Figure 37. Blood Purification Cartridge Sales by Company in 2025 (K Units)
Figure 38. Global Blood Purification Cartridge Sales Market Share by Company in 2025
Figure 39. Blood Purification Cartridge Revenue by Company in 2025 ($ millions)
Figure 40. Global Blood Purification Cartridge Revenue Market Share by Company in 2025
Figure 41. Global Blood Purification Cartridge Sales Market Share by Geographic Region (2021-2026)
Figure 42. Global Blood Purification Cartridge Revenue Market Share by Geographic Region in 2025
Figure 43. Americas Blood Purification Cartridge Sales 2021-2026 (K Units)
Figure 44. Americas Blood Purification Cartridge Revenue 2021-2026 ($ millions)
Figure 45. APAC Blood Purification Cartridge Sales 2021-2026 (K Units)
Figure 46. APAC Blood Purification Cartridge Revenue 2021-2026 ($ millions)
Figure 47. Europe Blood Purification Cartridge Sales 2021-2026 (K Units)
Figure 48. Europe Blood Purification Cartridge Revenue 2021-2026 ($ millions)
Figure 49. Middle East & Africa Blood Purification Cartridge Sales 2021-2026 (K Units)
Figure 50. Middle East & Africa Blood Purification Cartridge Revenue 2021-2026 ($ millions)
Figure 51. Americas Blood Purification Cartridge Sales Market Share by Country in 2025
Figure 52. Americas Blood Purification Cartridge Revenue Market Share by Country (2021-2026)
Figure 53. Americas Blood Purification Cartridge Sales Market Share by Type (2021-2026)
Figure 54. Americas Blood Purification Cartridge Sales Market Share by Application (2021-2026)
Figure 55. United States Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 56. Canada Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 57. Mexico Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 58. Brazil Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 59. APAC Blood Purification Cartridge Sales Market Share by Region in 2025
Figure 60. APAC Blood Purification Cartridge Revenue Market Share by Region (2021-2026)
Figure 61. APAC Blood Purification Cartridge Sales Market Share by Type (2021-2026)
Figure 62. APAC Blood Purification Cartridge Sales Market Share by Application (2021-2026)
Figure 63. China Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 64. Japan Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 65. South Korea Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 66. Southeast Asia Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 67. India Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 68. Australia Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 69. China Taiwan Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 70. Europe Blood Purification Cartridge Sales Market Share by Country in 2025
Figure 71. Europe Blood Purification Cartridge Revenue Market Share by Country (2021-2026)
Figure 72. Europe Blood Purification Cartridge Sales Market Share by Type (2021-2026)
Figure 73. Europe Blood Purification Cartridge Sales Market Share by Application (2021-2026)
Figure 74. Germany Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 75. France Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 76. UK Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 77. Italy Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 78. Russia Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 79. Middle East & Africa Blood Purification Cartridge Sales Market Share by Country (2021-2026)
Figure 80. Middle East & Africa Blood Purification Cartridge Sales Market Share by Type (2021-2026)
Figure 81. Middle East & Africa Blood Purification Cartridge Sales Market Share by Application (2021-2026)
Figure 82. Egypt Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 83. South Africa Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 84. Israel Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 85. Turkey Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 86. GCC Countries Blood Purification Cartridge Revenue Growth 2021-2026 ($ millions)
Figure 87. Manufacturing Cost Structure Analysis of Blood Purification Cartridge in 2026
Figure 88. Manufacturing Process Analysis of Blood Purification Cartridge
Figure 89. Industry Chain Structure of Blood Purification Cartridge
Figure 90. Channels of Distribution
Figure 91. Global Blood Purification Cartridge Sales Market Forecast by Region (2027-2032)
Figure 92. Global Blood Purification Cartridge Revenue Market Share Forecast by Region (2027-2032)
Figure 93. Global Blood Purification Cartridge Sales Market Share Forecast by Type (2027-2032)
Figure 94. Global Blood Purification Cartridge Revenue Market Share Forecast by Type (2027-2032)
Figure 95. Global Blood Purification Cartridge Sales Market Share Forecast by Application (2027-2032)
Figure 96. Global Blood Purification Cartridge Revenue Market Share Forecast by Application (2027-2032)
